Carboplatin/Durvalumab/Pemetrexed/Tremelimumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of carboplatin, durvalumab, pemetrexed and tremelimumab that may be used in the treatment of non-small cell lung cancer (NSCLC).

**Synonyms:** - Carboplatin-Durvalumab-Pemetrexed-Tremelimumab - Carboplatin/Durvalumab/Pemetrexed/Tremelimumab - Carboplatin/Durvalumab/Pemetrexed/Tremelimumab-actl - Carboplatin/Imjudo/Pemetrexed/Imfinzi - Imjudo/Imfinzi Plus Carboplatin/Pemetrexed - Tremelimumab/Durvalumab/Pemetrexed/Carboplatin